United States Pharmaceuticals

Medicines Co (MDCO)

Track

Medicines Co experienced significant insider activity throughout 2019, primarily characterized by substantial share acquisitions from Alexander J. Denner. The most recent recorded transaction occurred on August 2, 2019, involving a sale by an executive. Given these events transpired over three months ago, no current market performance analysis is provided.
Ticker: MDCO Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Sale 2 Aug 2019
Value US$4,058,608.31 | Price 476.57 | Shares 2,236 (+0.5%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2019-08-06 2019-08-02 S Sale Rodin Stephen M

EVP and General Counsel

Officer
2,236 +0.5%
476.57
US$4,058,608 		2,236 +0.5% 476.57 US$4,058,608
2019-06-28 2019-06-28 B Purchase
2.8
DENNER ALEXANDER J
98,846 -40.7%
94.31
US$4,745,491 		98,846 -40.7% 94.31 US$4,745,491
2019-05-31 2019-05-30 B Purchase
2.8
DENNER ALEXANDER J
Non-Executive Director
23,258 +5.7%
338.02
US$251,673 		23,258 +5.7% 338.02 US$251,673
2019-05-31 2019-05-29 B Purchase
2.8
DENNER ALEXANDER J
Non-Executive Director
35,000 +0.9%
34.85
US$1,219,750 		35,000 +0.9% 34.85 US$1,219,750
2019-05-22 2019-05-22 B Purchase
2.8
DENNER ALEXANDER J
Non-Executive Director
139,000 +3.5%
33.13
US$4,605,070 		139,000 +3.5% 33.13 US$4,605,070
2019-05-22 2019-05-21 B Purchase
2.8
DENNER ALEXANDER J
Non-Executive Director
132,000 +3.5%
33.95
US$4,481,400 		132,000 +3.5% 33.95 US$4,481,400
2019-05-22 2019-05-20 B Purchase
2.8
DENNER ALEXANDER J
Non-Executive Director
160,000 +4.4%
34.50
US$5,520,000 		160,000 +4.4% 34.50 US$5,520,000
2019-03-08 2019-03-06 B Purchase
2.8
DENNER ALEXANDER J
Non-Executive Director
248,100 +7.3%
24.91
US$6,180,171 		248,100 +7.3% 24.91 US$6,180,171
2019-03-05 2019-03-05 B Purchase
2.8
DENNER ALEXANDER J
Non-Executive Director
181,900 +5.7%
26.07
US$4,742,133 		181,900 +5.7% 26.07 US$4,742,133
2019-03-05 2019-03-04 B Purchase
2.8
DENNER ALEXANDER J
Non-Executive Director
325,000 +11.3%
25.45
US$8,271,250 		325,000 +11.3% 25.45 US$8,271,250
2019-03-05 2019-03-01 B Purchase
2.8
DENNER ALEXANDER J
Non-Executive Director
100,000 +3.6%
25.15
US$2,515,000 		100,000 +3.6% 25.15 US$2,515,000
2018-12-27 2018-12-21 B Purchase Timney Mark

Chief Executive Officer

Executive Director
2,926 +10.9%
17.90
US$52,375 		2,926 +10.9% 17.90 US$52,375
2018-12-21 2018-12-20 B Purchase Cox Christopher T

EVP & Chief Corp. Dev. Officer

Officer
113,500 +51.3%
17.70
US$2,008,950 		113,500 +51.3% 17.70 US$2,008,950
2018-12-21 2018-12-20 B Purchase DENNER ALEXANDER J Non-Executive Director
10,000 +0.4%
17.89
US$178,900 		10,000 +0.4% 17.89 US$178,900
2018-12-18 2018-12-18 B Purchase DENNER ALEXANDER J Non-Executive Director
10,000 +0.4%
18.18
US$181,800 		10,000 +0.4% 18.18 US$181,800
2018-12-18 2018-12-17 B Purchase DENNER ALEXANDER J Non-Executive Director
20,000 +0.7%
17.91
US$358,200 		20,000 +0.7% 17.91 US$358,200
2018-12-18 2018-12-17 B Purchase Timney Mark

Chief Executive Officer

Executive Director
26,863 +inf%
18.60
US$499,652 		26,863 +inf% 18.60 US$499,652
2018-12-17 2018-12-14 B Purchase DENNER ALEXANDER J Non-Executive Director
219,000 +8.7%
18.97
US$4,154,430 		219,000 +8.7% 18.97 US$4,154,430
2018-12-17 2018-12-13 B Purchase DENNER ALEXANDER J Non-Executive Director
600,000 +31.2%
20.73
US$12,438,000 		600,000 +31.2% 20.73 US$12,438,000
2018-11-19 2018-11-16 B Purchase Cox Christopher T

EVP & Chief Corp. Dev. Officer

Officer
50,300 +29.4%
19.73
US$992,419 		50,300 +29.4% 19.73 US$992,419
2018-09-05 2018-09-04 PlS Planned sale MEANWELL CLIVE

CEO

Executive Director
50,000 -14.2%
39.31
US$1,965,500 		50,000 -14.2% 39.31 US$1,965,500
2018-08-02 2018-08-01 S Sale MEANWELL CLIVE

CEO

Executive Director
50,000 -12.4%
39.24
US$1,962,000 		50,000 -12.4% 39.24 US$1,962,000
2018-07-05 2018-07-02 S Sale MEANWELL CLIVE

CEO

Executive Director
50,000 -11.1%
36.07
US$1,803,500 		50,000 -11.1% 36.07 US$1,803,500
2018-05-29 2018-05-25 S Sale Spigelman Melvin K Non-Executive Director
7,500 -12.4%
32.20
US$241,500 		7,500 -12.4% 32.20 US$241,500
2018-04-18 2018-04-16 PlS Planned sale KESSLER ARMIN M
10,000 -7.1%
30.05
US$300,500 		10,000 -7.1% 30.05 US$300,500
2018-03-23 2018-03-21 S Sale CROUSE WILLIAM
7,500 -12.4%
32.26
US$241,950 		7,500 -12.4% 32.26 US$241,950
2018-04-18 2018-01-16 PlS Planned sale KESSLER ARMIN M
10,000 -6.6%
27.37
US$273,700 		10,000 -6.6% 27.37 US$273,700
2017-12-19 2017-12-15 S Sale MEANWELL CLIVE

CEO

Executive Director
136,250 -23.2%
27.24
US$3,711,450 		136,250 -23.2% 27.24 US$3,711,450
2017-12-11 2017-12-08 B Purchase ESHELMAN FREDRIC N

Executive Chairman

Executive Director
100,000 +9.7%
26.65
US$2,665,000 		100,000 +9.7% 26.65 US$2,665,000
2017-12-11 2017-12-07 B Purchase ESHELMAN FREDRIC N

Executive Chairman

Executive Director
100,000 +10.8%
26.46
US$2,646,000 		100,000 +10.8% 26.46 US$2,646,000
2017-12-01 2017-11-30 B Purchase Panayiotopoulos Paris
3,215 +99.3%
30.97
US$99,569 		3,215 +99.3% 30.97 US$99,569
2017-11-30 2017-11-29 B Purchase DENNER ALEXANDER J
170,000 +9.7%
30.03
US$5,105,100 		170,000 +9.7% 30.03 US$5,105,100
2017-02-14 2017-02-10 PlS Planned sale O'Connor William Bernard

Chief Financial Officer

Officer
16,282 -44.8%
50.00
US$814,100 		16,282 -44.8% 50.00 US$814,100
2017-02-14 2017-02-10 PlS Planned sale O'Connor William Bernard

Chief Financial Officer

Officer
10,313 -33.9%
50.00
US$515,650 		10,313 -33.9% 50.00 US$515,650
2017-02-14 2017-02-10 PlS Planned sale O'Connor William Bernard

Chief Financial Officer

Officer
15,907 -44.2%
50.00
US$795,350 		15,907 -44.2% 50.00 US$795,350
2017-02-14 2017-02-10 PlS Planned sale O'Connor William Bernard

Chief Financial Officer

Officer
15,000 -42.7%
50.00
US$750,000 		15,000 -42.7% 50.00 US$750,000
2017-02-07 2017-02-07 PlS Planned sale O'Connor William Bernard

Chief Financial Officer

Officer
2,900 -12.6%
47.45
US$137,605 		2,900 -12.6% 47.45 US$137,605
2017-02-07 2017-02-07 PlS Planned sale O'Connor William Bernard

Chief Financial Officer

Officer
12,100 -34.5%
46.98
US$568,458 		12,100 -34.5% 46.98 US$568,458
2017-02-07 2017-02-03 PlS Planned sale O'Connor William Bernard

Chief Financial Officer

Officer
10,833 -35.0%
45.00
US$487,485 		10,833 -35.0% 45.00 US$487,485
2016-12-09 2016-12-08 B Purchase Cox Christopher T

EVP & Chief Corp. Dev. Officer

Officer
16,500 +10.7%
32.52
US$536,580 		16,500 +10.7% 32.52 US$536,580
2016-12-08 2016-12-08 B Purchase ESHELMAN FREDRIC N Non-Executive Director
5,501 +0.6%
33.19
US$182,578 		5,501 +0.6% 33.19 US$182,578
2016-12-08 2016-12-08 B Purchase ESHELMAN FREDRIC N Non-Executive Director
19,188 +2.1%
32.51
US$623,802 		19,188 +2.1% 32.51 US$623,802
2016-12-09 2016-12-07 B Purchase Cox Christopher T

EVP & Chief Corp. Dev. Officer

Officer
89,000 +135.6%
33.33
US$2,966,370 		89,000 +135.6% 33.33 US$2,966,370
2016-12-08 2016-12-07 B Purchase ESHELMAN FREDRIC N Non-Executive Director
86,587 +10.6%
32.90
US$2,848,712 		86,587 +10.6% 32.90 US$2,848,712
2016-12-08 2016-12-07 B Purchase ESHELMAN FREDRIC N Non-Executive Director
172,764 +26.9%
33.61
US$5,806,598 		172,764 +26.9% 33.61 US$5,806,598
2016-12-08 2016-12-06 B Purchase ESHELMAN FREDRIC N Non-Executive Director
337,680 +111.3%
34.15
US$11,531,772 		337,680 +111.3% 34.15 US$11,531,772
2016-11-17 2016-11-15 S Sale MEANWELL CLIVE

CEO

Executive Director
20,000 -5.6%
40.00
US$800,054 		20,000 -5.6% 40.00 US$800,054
2016-09-23 2016-09-21 S Sale MEANWELL CLIVE

CEO

Executive Director
8,623 -2.5%
40.00
US$344,920 		8,623 -2.5% 40.00 US$344,920
2016-09-02 2016-09-01 S Sale MEANWELL CLIVE

CEO

Executive Director
1,377 -0.4%
40.00
US$55,080 		1,377 -0.4% 40.00 US$55,080
2016-08-25 2016-08-24 S Sale MEANWELL CLIVE

CEO

Executive Director
20,000 -5.6%
40.00
US$800,000 		20,000 -5.6% 40.00 US$800,000
2016-07-13 2016-07-11 PlS Planned sale Shigeta Hiroaki Non-Executive Director
3,849 -14.0%
38.50
US$148,186 		3,849 -14.0% 38.50 US$148,186
2016-06-20 2016-06-13 PlS Planned sale Shigeta Hiroaki Non-Executive Director
20,000 -42.2%
36.76
US$735,200 		20,000 -42.2% 36.76 US$735,200
2016-06-10 2016-06-10 B Purchase Cox Christopher T

EVP & Chief Corp. Dev. Officer

Officer
6,670 +24.7%
37.21
US$248,191 		6,670 +24.7% 37.21 US$248,191
2016-06-10 2016-06-10 B Purchase Cox Christopher T

EVP & Chief Corp. Dev. Officer

Officer
13,340 +25.5%
37.22
US$496,515 		13,340 +25.5% 37.22 US$496,515
2016-06-10 2016-06-08 B Purchase Cox Christopher T

EVP & Chief Corp. Dev. Officer

Officer
25,975 +98.6%
38.43
US$998,219 		25,975 +98.6% 38.43 US$998,219
2016-06-08 2016-06-07 B Purchase Cox Christopher T

EVP & Chief Corp. Dev. Officer

Officer
26,340 +inf%
37.96
US$999,866 		26,340 +inf% 37.96 US$999,866
2016-06-08 2016-06-07 B Purchase Cox Christopher T

EVP & Chief Corp. Dev. Officer

Officer
6,200 +29.8%
37.49
US$232,438 		6,200 +29.8% 37.49 US$232,438
2016-06-08 2016-06-07 B Purchase Cox Christopher T

EVP & Chief Corp. Dev. Officer

Officer
20,800 +inf%
37.05
US$770,640 		20,800 +inf% 37.05 US$770,640
2016-05-26 2016-05-24 S Sale Savage Robert G. Non-Executive Director
10,000 -26.5%
36.95
US$369,500 		10,000 -26.5% 36.95 US$369,500
2016-05-26 2016-05-24 S Sale Spigelman Melvin K Non-Executive Director
15,000 -27.8%
37.00
US$555,000 		15,000 -27.8% 37.00 US$555,000
2016-05-18 2016-05-16 S Sale MEANWELL CLIVE

CEO

Executive Director
10,000 -2.9%
35.00
US$350,000 		10,000 -2.9% 35.00 US$350,000
2016-05-18 2016-05-16 S Sale CROUSE WILLIAM Non-Executive Director
15,000 -27.8%
35.15
US$527,295 		15,000 -27.8% 35.15 US$527,295
2016-05-13 2016-05-13 S Sale WYATT ELIZABETH H S Non-Executive Director
4,153 -9.6%
34.00
US$141,202 		4,153 -9.6% 34.00 US$141,202
2016-05-13 2016-05-12 B Purchase ESHELMAN FREDRIC N Non-Executive Director
300,000 +inf%
33.68
US$10,104,000 		300,000 +inf% 33.68 US$10,104,000
2016-05-13 2016-05-11 S Sale WYATT ELIZABETH H S Non-Executive Director
10,847 -21.8%
34.09
US$369,796 		10,847 -21.8% 34.09 US$369,796
2016-03-08 2016-03-07 S Sale KESSLER ARMIN M Non-Executive Director
8,100 -5.6%
34.82
US$282,042 		8,100 -5.6% 34.82 US$282,042
2016-03-08 2016-03-04 PlS Planned sale O'Connor William Bernard

Chief Financial Officer

Officer
5,287 -21.1%
34.01
US$179,811 		5,287 -21.1% 34.01 US$179,811
2016-03-08 2016-03-04 PlS Planned sale O'Connor William Bernard

Chief Financial Officer

Officer
3,330 -11.7%
35.00
US$116,550 		3,330 -11.7% 35.00 US$116,550
2015-11-16 2015-11-13 S Sale Savage Robert G. Non-Executive Director
5,000 -15.3%
39.34
US$196,700 		5,000 -15.3% 39.34 US$196,700
2015-09-04 2015-09-03 PlS Planned sale SBLENDORIO GLENN

President & CFO

Executive Director
25,000 -20.0%
42.00
US$1,050,000 		25,000 -20.0% 42.00 US$1,050,000
2015-09-02 2015-08-31 PlS Planned sale MEANWELL CLIVE

CEO

Executive Director
49,998 -13.3%
39.36
US$1,967,871 		49,998 -13.3% 39.36 US$1,967,871
2015-09-02 2015-08-31 PlS Planned sale SBLENDORIO GLENN

President & CFO

Executive Director
114,495 -53.4%
39.75
US$4,551,600 		114,495 -53.4% 39.75 US$4,551,600
2015-09-02 2015-08-31 S Sale Spigelman Melvin K Non-Executive Director
20,000 -33.9%
40.50
US$810,000 		20,000 -33.9% 40.50 US$810,000
2015-09-02 2015-08-31 PlS Planned sale O'Connor William Bernard

SVP & Chief Acct. Officer

Officer
35,451 -58.9%
40.00
US$1,418,040 		35,451 -58.9% 40.00 US$1,418,040
2015-08-04 2015-08-03 PlS Planned sale MEANWELL CLIVE

Chairman & CEO

Executive Director
16,667 -4.9%
30.96
US$515,960 		16,667 -4.9% 30.96 US$515,960
Explore more

More insider trading research around Medicines Co

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America